Skip to content
10-Q

Quarterly Report

Biohaven Pharmaceutical Holding Company Ltd.

0001689813-22-000064

← back to feed
Filed
Aug 5, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 4, 2022 71.49M sh
Shares Diluted Q2 2022 · Jun 30, 2022 71.04M sh
Shares Diluted Q2 2022 · Jun 30, 2022 70.69M sh
Shares Diluted Q2 2022 · Jun 30, 2021 65.11M sh
Shares Diluted Q2 2022 · Jun 30, 2021 63.58M sh
Capex Q2 2022 · Jun 30, 2022 $2.39M
Capex Q2 2022 · Jun 30, 2021 $1.66M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$157.68M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$432.72M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $235.81M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $171.95M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$800.93M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$739.38M
Current Liabilities Q2 2022 · Jun 30, 2022 $671.96M
Current Liabilities Q2 2022 · Dec 31, 2021 $534.2M
Total Liabilities Q2 2022 · Jun 30, 2022 $2.19B
Total Liabilities Q2 2022 · Dec 31, 2021 $1.76B
Current Assets Q2 2022 · Jun 30, 2022 $1.17B
Current Assets Q2 2022 · Dec 31, 2021 $876.25M
Total Assets Q2 2022 · Jun 30, 2022 $1.39B
Total Assets Q2 2022 · Dec 31, 2021 $1.08B
Eps Diluted Q2 2022 · Jun 30, 2022 −$6.21
Eps Diluted Q2 2022 · Jun 30, 2022 −$9.20
Eps Diluted Q2 2022 · Jun 30, 2021 −$3.23
Eps Diluted Q2 2022 · Jun 30, 2021 −$7.48
Eps Basic Q2 2022 · Jun 30, 2022 −$6.21
Eps Basic Q2 2022 · Jun 30, 2022 −$9.20
Eps Basic Q2 2022 · Jun 30, 2021 −$3.23
Eps Basic Q2 2022 · Jun 30, 2021 −$7.48
Sga Expense Q2 2022 · Jun 30, 2022 $250.46M
Sga Expense Q2 2022 · Jun 30, 2022 $477.7M
Sga Expense Q2 2022 · Jun 30, 2021 $170.06M
Sga Expense Q2 2022 · Jun 30, 2021 $329.58M
Rd Expense Q2 2022 · Jun 30, 2022 $218.48M
Rd Expense Q2 2022 · Jun 30, 2022 $337.58M
Rd Expense Q2 2022 · Jun 30, 2021 $77.43M
Rd Expense Q2 2022 · Jun 30, 2021 $184.54M
Operating Income Q2 2022 · Jun 30, 2022 −$289.6M
Operating Income Q2 2022 · Jun 30, 2022 −$343.43M
Operating Income Q2 2022 · Jun 30, 2021 −$171.89M
Operating Income Q2 2022 · Jun 30, 2021 −$407.56M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $35.74M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $62.08M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $17.34M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $30.2M
Revenue Q2 2022 · Jun 30, 2022 $215.08M
Revenue Q2 2022 · Jun 30, 2022 $533.93M
Revenue Q2 2022 · Jun 30, 2021 $92.93M
Revenue Q2 2022 · Jun 30, 2021 $136.76M